SGLT2 Inhibitors in Diabetes:

SGLT2 inhibitors (Sodium-Glucose Cotransporter-2 inhibitors) are a class of medications that have revolutionized the treatment of Type 2 Diabetes. These drugs work by blocking the SGLT2 protein in the kidneys, preventing glucose reabsorption and promoting its excretion through urine. This helps lower blood sugar levels independently of insulin. In addition to improving glycemic control, SGLT2 inhibitors have been shown to provide cardiovascular and renal benefits, reducing the risk of heart failure, kidney disease, and diabetic complications. Recent studies have also highlighted their potential role in weight loss and blood pressure reduction. Given these multiple benefits, SGLT2 inhibitors are increasingly recommended for patients with Type 2 Diabetes, especially those with coexisting cardiovascular or kidney conditions.

    Related Conference of SGLT2 Inhibitors in Diabetes:

    January 27-28, 2025

    29th International Conference on Diabetes, Endocrinology and Healthcare

    Dubai, UAE
    February 24-25, 2025

    34th European Diabetes Congress

    London, UK
    February 24-25, 2025

    20th International Conference on Endocrinology and Metabolic Disorders

    London, UK
    March 10-11, 2025

    18th European Diabetes and Endocrinology Congress

    Rome, Italy
    March 10-11, 2025

    4th Global Summit on Physiology and Metabolism of Thyroid

    Singapore City, Singapore
    March 17-18, 2025

    19th International Conference on Endocrinology, Diabetes and Metabolism

    Singapore City, Singapore
    March 17-18, 2025

    5th European Endocrinology and Diabetes Congress

    Paris, France
    March 24-25, 2025

    6th Global summit on Diabetes and Endocrinology

    London, UK
    April 07-08, 2025

    36th International Congress on Prevention of Diabetes and Complications

    Vancouver, Canada
    April 10-11, 2025

    27th World Congress on Diabetes and Endocrine Disorders

    Dubai, UAE
    April 10-11, 2025

    4th International Summit on Hormonal Disorders

    Dubai, UAE
    April 10-11, 2025

    5th World Congress on Endocrine and Diabetes

    Dubai, UAE
    April 10-11, 2025

    31st International Conference on Human Metabolic Health- Diabetes, Obesity & Endocrinology

    Dubai, UAE
    April 16-17, 2025

    9th International Conference on Diabetes and Cholesterol Metabolism

    Tokyo, Japan
    May 05-06, 2025

    24th International Conference on Diabetes, Nutrition, Obesity and Eating Disorders

    Rome, Italy
    May 12-13, 2025

    2nd International Congress on Endocrinology and Complications of Diabetes

    Rome, Italy
    May 19-20, 2025

    6th World Summit on Diabetes

    Rome, Italy
    June 04-05, 2025

    4th World Congress on Diabetes and Pediatric Endocrinology

    Edinburgh, Scotland
    June 24-25, 2025

    23rd Global Conference on Diabetes, Endocrinology and Primary Healthcare

    Paris, France
    July 29-30, 2025

    15th World Congress on Endocrinology and Diabetes

    Aix-en-Provence, France
    August 11-12, 2025

    5th International Conference on Endocrinology and Diabetes

    Toronto, Canada
    August 28-29, 2025

    34th International Diabetes and Healthcare Conference

    London, UK
    September 08-09, 2025

    3rd World congress and Expo on Diabetes

    Frankfurt, Germany
    October 30-31, 2025

    5th Annual Summit on Diabetes and Endocrinology

    Paris, France
    November 06-07, 2025

    34th International Conference on Clinical Diabetes, Diabetic Medication & Treatment

    Berlin, Germany
    November 06-07, 2025

    8th Annual Meeting on Diabetes and Endocrinology

    Dubai, UAE
    November 20-21, 2025

    21st World Congress on Endocrinology & Diabetes

    Paris, France

    SGLT2 Inhibitors in Diabetes: Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in